Arkolith/Insider Trading/ABIO/Form 4

Funicular Funds, LP

10% OwnerARCA biopharma, Inc. (ABIO) · full profile →Form 4 · filed Dec 19, 2022
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
4
1 non-derivative · 3 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 16, 2022Option exercise(X)1.4M$2.50$3.5M4.0M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Dec 16, 2022Expiration(E)300—$00
Dec 16, 2022Option exercise(X)14K—$030K
Dec 15, 2022Grant(A)6K—$018K

Transaction Codes

X
Exercise of in-the-money derivative
E
See SEC Form 4 code table
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000921895-22-003245) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML